TREA

88873084 - SIGRID THERAPEUTICS

Follow

Information

  • Trademark
  • 88873084
  • Serial Number
    88873084
  • Filing Date
    April 15, 2020
    5 years ago
  • Transaction Date
    February 13, 2024
    a year ago
  • Status Date
    November 20, 2023
    a year ago
  • Published for Opposition Date
    August 25, 2020
    4 years ago
  • Location Date
    March 14, 2023
    2 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CLARK, ANDREW T
  • Attorney Name
    Bradley L. Cohn
    Law Office Assigned Location Code
    L70
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
SIGRID THERAPEUTICS
Case File Statements
  • GS0051: Dietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceuticals and natural remedies for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients, and not including products primarily for use in the treatment of angina pectoris and high blood pressure
  • GS0101: Surgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients
  • D10000: "THERAPEUTICS"
Case File Event Statements
  • 11/20/2023 - a year ago
    36 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 11/20/2023 - a year ago
    35 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 3/15/2023 - 2 years ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 3/14/2023 - 2 years ago
    33 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 3/2/2023 - 2 years ago
    32 - SOU EXTENSION 5 FILED Type: EXT5
  • 3/14/2023 - 2 years ago
    31 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 3/2/2023 - 2 years ago
    30 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 9/10/2022 - 2 years ago
    29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/8/2022 - 2 years ago
    28 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 9/8/2022 - 2 years ago
    27 - SOU EXTENSION 4 FILED Type: EXT4
  • 9/8/2022 - 2 years ago
    26 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/9/2022 - 3 years ago
    25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 2/7/2022 - 3 years ago
    24 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 2/7/2022 - 3 years ago
    23 - SOU EXTENSION 3 FILED Type: EXT3
  • 2/7/2022 - 3 years ago
    22 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/8/2021 - 3 years ago
    21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/6/2021 - 3 years ago
    20 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/6/2021 - 3 years ago
    19 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/6/2021 - 3 years ago
    18 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/16/2021 - 4 years ago
    17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/14/2021 - 4 years ago
    16 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 4/14/2021 - 4 years ago
    15 - SOU EXTENSION 1 FILED Type: EXT1
  • 4/14/2021 - 4 years ago
    14 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/20/2020 - 4 years ago
    13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/25/2020 - 4 years ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/25/2020 - 4 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/5/2020 - 5 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/20/2020 - 5 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 7/17/2020 - 5 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/17/2020 - 5 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/17/2020 - 5 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/17/2020 - 5 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/17/2020 - 5 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/6/2020 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/24/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/18/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP